Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Current Hypertension Reports|July 20, 2019
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure GuidelinesGuido Grassi, David A Calhoun, Giuseppe Mancia, et al.
Expert Review of Cardiovascular Therapy|May 24, 2006
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertensionKrishna K Gaddam, Monique N Pratt-Ubunama, David A Calhoun
Current Problems in Cardiology|January 13, 2009
Aldosterone and cardiovascular diseaseKrishna K Gaddam, Eduardo Pimenta, Saima Husain, et al.
Hypertension (Dallas, Tex. : 1979)|July 12, 2017
White-Coat Effect Is Uncommon in Patients With Refractory HypertensionMohammed Siddiqui, Eric K Judd, Suzanne Oparil, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trialDavid A Calhoun, Yves Lacourcière, Yann Tong Chiang, et al.
Advances in Therapy|December 22, 2009
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safetyDavid A Calhoun, Nora A Crikelair, Joseph Yen, et al.
Circulation Research|March 29, 2019
Treatment of Resistant and Refractory HypertensionMaria Czarina Acelajado, Zachary H Hughes, Suzanne Oparil, et al.
Vascular Health and Risk Management|July 10, 2013
Aldosterone receptor antagonists: current perspectives and therapiesJason L Guichard, Donald Clark, David A Calhoun, et al.
Postgraduate Medicine|February 9, 2012
Recent advancements in the treatment of resistant hypertensionDonald Clark, Jason L Guichard, David A Calhoun, et al.
Chest|January 14, 2004
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apneaDavid A Calhoun, Mari K Nishizaka, Mohammad A Zaman, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Current Hypertension Reports|July 20, 2019
Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure GuidelinesGuido Grassi, David A Calhoun, Giuseppe Mancia, et al.
Expert Review of Cardiovascular Therapy|May 24, 2006
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertensionKrishna K Gaddam, Monique N Pratt-Ubunama, David A Calhoun
Current Problems in Cardiology|January 13, 2009
Aldosterone and cardiovascular diseaseKrishna K Gaddam, Eduardo Pimenta, Saima Husain, et al.
Hypertension (Dallas, Tex. : 1979)|July 12, 2017
White-Coat Effect Is Uncommon in Patients With Refractory HypertensionMohammed Siddiqui, Eric K Judd, Suzanne Oparil, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2009
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trialDavid A Calhoun, Yves Lacourcière, Yann Tong Chiang, et al.
Advances in Therapy|December 22, 2009
Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safetyDavid A Calhoun, Nora A Crikelair, Joseph Yen, et al.
Circulation Research|March 29, 2019
Treatment of Resistant and Refractory HypertensionMaria Czarina Acelajado, Zachary H Hughes, Suzanne Oparil, et al.
Vascular Health and Risk Management|July 10, 2013
Aldosterone receptor antagonists: current perspectives and therapiesJason L Guichard, Donald Clark, David A Calhoun, et al.
Postgraduate Medicine|February 9, 2012
Recent advancements in the treatment of resistant hypertensionDonald Clark, Jason L Guichard, David A Calhoun, et al.
Chest|January 14, 2004
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apneaDavid A Calhoun, Mari K Nishizaka, Mohammad A Zaman, et al.
Pageof 19